Why Exactech Skyrocketed 31% Today
After agreeing to be taken private by global alternative asset manager TPG Capital, Exactech (NASDAQ: EXAC) jumped 31% today.
Exactech makes orthopedic implant devices and related surgical instruments that it markets to hospitals and doctors. Aging baby boomers are increasing the number of orthopedic procedures done every year, and private equity manager TPG thinks it can accelerate market share over time by owning the company outright.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Johnson & Johnson Aktie
Johnson & Johnson erfreut sich großer Beliebtheit, mit einer hohen Zahl an Buy- und niedriger Zahl an Sell-Einschätzungen.
Das Kursziel von 194 € für Johnson & Johnson impliziert eine deutliche Steigerung um über 20% gegenüber 148.28 €.